ChemPartner PharmaTech Co Ltd (300149.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Biotechnology · China · ISIN CNE100000Y27

Price
9.09 CNY
Market cap
4.53 bn CNY
P/E (2025)
337.49
P/S (2025)
3.99
Dividend yield
0.00 %
Net margin
1.18 %
Return on equity (ROE)
1.05 %
Return on assets (ROA)
0.66 %

ChemPartner PharmaTech Co Ltd financials

Fiscal year20242025
Revenue970.20 m CNY1.13 bn CNY
Gross profit211.51 m CNY324.69 m CNY
Operating income-42.74 m CNY39.10 m CNY
EBIT-205.55 m CNY31.88 m CNY
Net income-226.47 m CNY13.41 m CNY
Diluted EPS – continuing operations-0.45 CNY0.03 CNY

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About ChemPartner PharmaTech Co Ltd

ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehensive chemical drug research and development and biological drug services for pharmaceutical companies, biotechnology companies, and scientific research institutions. The company was formerly known as Quantum Hi-Tech (China) Biological Co., Ltd. and changed its name to ChemPartner PharmaTech Co.,Ltd. in September 2020. ChemPartner PharmaTech Co.,Ltd. was founded in 2000 and is headquartered in Guangzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.